Inhibition of the formation or action of angiotensin II reverses attenuated K + currents in type 1 and type 2 diabetes

The Journal of Physiology ◽

10.1111/j.1469-7793.2001.0083k.x ◽

2001 ◽

Vol 537 (1) ◽

pp. 83-92 ◽

Author(s):

Yakhin Shimoni

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Download Full-text

SUPPRESSION OF ADVANCED GLYCATION AND LIPOXIDATION END PRODUCTS BY AN ANGIOTENSIN II TYPE-1 RECEPTOR BLOCKER IN ESSENTIAL HYPERTENSION WITH TYPE-2 DIABETES MELLITUS

Journal of Hypertension ◽

10.1097/00004872-200402001-00789 ◽

2004 ◽

Vol 22 (Suppl. 1) ◽

pp. S185

Author(s):

Y Ono ◽

K Mizuno ◽

M Takahashi ◽

Y Miura

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Essential Hypertension ◽

Angiotensin Ii ◽

Receptor Blocker ◽

Advanced Glycation ◽

Download Full-text

Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus

European Journal of Internal Medicine ◽

10.1016/j.ejim.2010.01.014 ◽

2010 ◽

Vol 21 (3) ◽

pp. 236-239 ◽

Author(s):

Nobuaki Ozaki ◽

Yoshio Nomura ◽

Hiroshi Sobajima ◽

Kunikazu Kondo ◽

Yutaka Oiso

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Angiotensin Ii ◽

Metabolic Parameters ◽

Receptor Type ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients

Download Full-text

Correlation between gene polymorphism in angiotensin II type 1 receptor and type 2 diabetes mellitus complicated by hypertension in a population of Inner Mongolia

BMC Medical Genetics ◽

10.1186/s12881-020-01021-1 ◽

2020 ◽

Vol 21 (1) ◽

Author(s):

Lina Hou ◽

Xiaohong Quan ◽

Xian Li ◽

Xiulan Su

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Angiotensin Ii ◽

Gene Polymorphism ◽

Download Full-text

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES

Kuban Scientific Medical Bulletin ◽

10.25207/1608-6228-2017-24-3-11-16 ◽

2017 ◽

Vol 24 (3) ◽

pp. 11-16

Author(s):

Z. V. BITAROVA ◽

O. V. REMIZOV ◽

Z. T. ASTAKHOVА

Keyword(s):

Heart Failure ◽

Type 2 Diabetes ◽

Coronary Heart Disease ◽

Heart Disease ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Ace Inhibitor ◽

Patients With Heart Failure

Download Full-text

Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

Heart and Vessels ◽

10.1007/s00380-019-01374-5 ◽

2019 ◽

Vol 35 (4) ◽

pp. 603-604

Author(s):

Satoshi Imaizumi ◽

◽

Yuhei Shiga ◽

Masahiro Ogawa ◽

Hideto Sako ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Essential Hypertension ◽

Angiotensin Ii ◽

Calcium Channel ◽

Randomized Trial ◽

Channel Blocker

Download Full-text

12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance

International Journal of Molecular Sciences ◽

10.3390/ijms17050684 ◽

2016 ◽

Vol 17 (5) ◽

pp. 684 ◽

Author(s):

Hong-Zhao Xu ◽

Yan-Li Cheng ◽

Wan-Ning Wang ◽

Hao Wu ◽

Yuan-Yuan Zhang ◽

...

Keyword(s):

Insulin Resistance ◽

Type 2 Diabetes ◽

Angiotensin Ii ◽

Lipoxygenase Inhibition ◽

12 Lipoxygenase

Download Full-text

Effects of Olmesartan Medoxomil, an Angiotensin II Type 1 Receptor Antagonist, on Plasma Concentration of B-Type Natriuretic Peptide, in Hypertensive Patients with Type 2 Diabetes Mellitus

Clinical Drug Investigation ◽

10.2165/11586510-000000000-00000 ◽

2011 ◽

Vol 31 (4) ◽

pp. 237-245 ◽

Author(s):

Toshihide Kawai ◽

Izumi Takei ◽

Akira Shimada ◽

Takumi Hirata ◽

Kumiko Tanaka ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Angiotensin Ii ◽

Plasma Concentration ◽

Receptor Antagonist ◽

Olmesartan Medoxomil ◽

Hypertensive Patients

Download Full-text

The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes

Diabetes Care ◽

10.2337/diacare.28.9.2261 ◽

2005 ◽

Vol 28 (9) ◽

pp. 2261-2266 ◽

Author(s):

E. L. Gillespie ◽

C. M. White ◽

M. Kardas ◽

M. Lindberg ◽

C. I. Coleman

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Ace Inhibitors ◽

Receptor Blockers ◽

Download Full-text

Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

Heart and Vessels ◽

10.1007/s00380-018-1286-2 ◽

2018 ◽

Vol 34 (4) ◽

pp. 698-710 ◽

Author(s):

Satoshi Imaizumi ◽

◽

Yuhei Shiga ◽

Masahiro Ogawa ◽

Hideto Sako ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Essential Hypertension ◽

Angiotensin Ii ◽

Calcium Channel ◽

Randomized Trial ◽

Channel Blocker

Download Full-text

Combination of the Dipeptidyl Peptidase IV Inhibitor LAF237 [(S)-1-[(3-Hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the Angiotensin II Type 1 Receptor Antagonist Valsartan [N-(1-Oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl]-l-valine] Enhances Pancreatic Islet Morphology and Function in a Mouse Model of Type 2 Diabetes

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.108.142703 ◽

2008 ◽

Vol 327 (3) ◽

pp. 683-691 ◽

Author(s):

Qianni Cheng ◽

Pui Ki Law ◽

Marc de Gasparo ◽

Po Sing Leung

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Mouse Model ◽

Receptor Antagonist ◽

Pancreatic Islet ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase Iv ◽

Download Full-text